Measuring the Impact of Trigeminal Neuralgia Pain: the Penn Facial Pain Scale-Revised
Overview
Authors
Affiliations
Background And Objective: The Penn Facial Pain Scale (Penn-FPS) was originally developed as a supplemental module to the Brief Pain Inventory Pain Interference Index (BPI-PII) in order to fully assess the impact of trigeminal neuralgia (TN) pain on patients' health-related quality of life (HRQoL). The current objective is to create and establish the content validity of a new stand-alone version of the measure, the Penn-FPS-Revised (Penn-FPS-R).
Methods: Twenty participants (15 USA and 5 UK) with confirmed TN engaged in concept elicitation and cognitive debriefing interviews. These semi-structured interviews allowed participants to spontaneously describe the ways in which TN impacts on HRQoL and report on the extent to which the Penn-FPS and BPI-PII measure concepts are most relevant to them. Participants were also asked to report on the suitability of the instructions, recall period, and response options.
Results: Concept elicitation revealed nine themes involving TN restrictions on daily activities and HRQoL, including: "talking," "self-care," "eating," "eating hard foods/chewing foods," "daily activities," "activities with temperature change," "touching," "mood," and "relationships." Cognitive debriefing confirmed that all of the Penn-FPS concepts and some of the BPI-PII concepts ("mood," "general activities," and "relations with others") were relevant, although some items required edits to better capture individuals' experiences. The impact of temperature and/or weather on activities was also identified as an important concept that is not captured by the Penn-FPS or BPI-PII. Participants confirmed the acceptability of recall period, instructions, and response options. Results from the interviews were applied to create the Penn-FPS-R, a new brief outcome measure that assesses the impacts of TN most important to patients.
Conclusion: The Penn-FPS-R is a new 12-item HRQoL outcome measure with content validity that can be used to assess and monitor the impact of TN treatment interventions in both clinical practice and research.
Trigeminal Neuralgia: Disease Characterization and Prediction of Response to Surgical Intervention.
Lam J, Sankar T, Sekula R, Senatus P, Patil P Curr Pain Headache Rep. 2025; 29(1):37.
PMID: 39873810 DOI: 10.1007/s11916-024-01316-5.
Gomes-da Silva de Rosenzweig P, Pastrana-Brandes S, Merikansky-Gerson S, Victoria-Garcia L, Curtius-Caruso M, Carrillo-Ruiz J J Dent Anesth Pain Med. 2024; 24(4):227-243.
PMID: 39118815 PMC: 11304043. DOI: 10.17245/jdapm.2024.24.4.227.
Li J, Deng Q, Zhao S, Sun J BMC Nurs. 2024; 23(1):436.
PMID: 38926673 PMC: 11202246. DOI: 10.1186/s12912-024-01851-x.
Blue R, Yang A, Ajmera S, Spadola M, Howard S, Saylany A J Neurol Surg B Skull Base. 2024; 85(3):287-294.
PMID: 38721365 PMC: 11076079. DOI: 10.1055/a-2065-9650.
Sun B, Zhang C, Huang K, Bhetuwal A, Yang X, Jing C Front Neurosci. 2024; 18:1381085.
PMID: 38576866 PMC: 10991788. DOI: 10.3389/fnins.2024.1381085.